Impact of plasma aldosterone levels for prediction of in-stent restenosis

American Journal of Cardiology

Volumn 97, Issue 6, 2006, Pages 785-788

  Amano, Tetsuya ^a   Matsubara, Tatsuaki ^b   Izawa, Hideo ^a   Torigoe, Masayuki ^a   Yoshida, Tomohiro ^a   Hamaguchi, Yukihisa ^a   Ishii, Hideki ^a   Miura, Manabu ^a   Hayashi, Yuzo ^a   Ogawa, Yasuhiro ^a   Murohara, Toyoaki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TICLOPIDINE;

AGED; ALDOSTERONE BLOOD LEVEL; ANGIOGRAPHY; ANGIOPLASTY; ARTICLE; CARDIOVASCULAR DISEASE; CORONARY STENT; FEMALE; FOLLOW UP; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTENOSIS; STABLE ANGINA PECTORIS;

AGED; ALDOSTERONE; ANGINA PECTORIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHOLESTEROL, LDL; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; FEMALE; FIBRINOGEN; FOLLOW-UP STUDIES; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RENIN; ROC CURVE; STENTS;

EID: 33644603370     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.10.017     Document Type: Article

References (9)

1. A. Sato, T. Saruta Aldosterone breakthrough during angiotensin-converting enzyme inhibitor therapy Am J Hypertens 16 2003 781 788
2. N. Naruse, A. Tanabe, A. Sato, S. Takagi, K. Tsuchiya, T. Imaki, K. Takano Aldosterone breakthrough during angiotensin II receptor antagonist therapy in stroke-prone spontaneously hypertensive rats Hypertension 40 2002 28 33
3. W. Qin, A.E. Rudolph, B.R. Bond, R. Rocha, E.A. Blomme, J.J. Goellner, J.W. Funder, E.G. McMahon Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure Circ Res 93 2003 69 76
4. R. Rocha, A.E. Rudolph, G.E. Frierdich, D.A. Nachowiak, B.K. Kekec, E.A. Blomme, E.G. McMahon, J.A. Delyani Aldosterone induces a vascular inflammatory phenotype in the rat heart Am J Physiol Heart Circ Physiol 283 suppl 2002 H1802 H1810
5. R. Rocha, C.T. Stier Jr Pathophysiological effects of aldosterone in cardiovascular tissues Trends Endocrinol Metab 12 2001 308 314
6. Y.C. Tae, J.B. Laura, P. Howard Aldosterone inhibits inducible nitric oxide synthase in neonatal rat cardiomyocytes Endocrinology 144 2003 1712 1717
7. U. Ikeda, T. Kanbe, I. Nakayama, Y. Kawahara, M. Yokoyama, K. Shimada Aldosterone inhibits nitric oxide synthesis in rat vascular smooth muscle cells induced by interleukin-1β Eur J Pharmacol 290 1995 69 73
8. H. Hatakeyama, I. Miyamori, T. Fujita, Y. Takeda, R. Takeda, H. Yamamoto Vascular aldosterone; biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells J Biol Chem 269 1994 14316 14320
9. B.E. Van, C. Bauters, N. Wernert, M. Hamon, E.P. McFardden, A. Racadot, B. Dupuis, J.M. Lablanche, M.E. Bertrand Neointimal thickening after balloon denudation is enhanced by aldosterone and inhibited by spironolactone, an aldosterone antagonist Cardiovasc Res 29 1995 27 32